This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Ask the Experts: EU CTR/CTIS: Adoption and Early Experience
Published on: Apr 14th, 2022
The EU Clinical Trials Regulation no. 536/2014 became effective on 31 January 2022 and the first approved trials are now showing up in CTIS. Nevertheless, planning ahead for a successful submission and knowing what to expect from the new system can be a challenge.
In this session, our experts answered questions related to the changes made and points to be noted, such as:
- Are you wondering when you should transition your ongoing trial to the EU CTR?
- Whether you can switch from the trial-centric approach to the organization-centric approach?
- How and to whom to submit your safety reports under the EU CTR?
Download: Answers to the key questions
Access the full webinar replay now
Fill in the form to download the content